.After a couple of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma crease, taking up the best science place at Sanofi.Quigley will start Sept. 30 as the French Big Pharma’s primary clinical police officer and also international chief of analysis, Sanofi told Tough Biotech in an emailed claim.Quigley is replacing Frank Nestle, M.D., that left Sanofi this spring amid a global overhaul of the firm’s R&D system. Nestle, that spent 8 years with the pharma, jumped over to Deerfield Management, where he currently works as a companion on the rehabs staff and CEO of the agency’s therapeutic exploration and also development procedures.
Quigley will join Sanofi coming from a San Francisco-based biotech that resides in stealth, depending on to his LinkedIn profile page. He’s presently listed as the business’s founder, president and chief executive officer.Since August 2021, Quigley has actually functioned as a project partner at SV Health and wellness Investors, a healthcare fund manager along with present assets in biotechs like BioAge, Cerevance, Dualitas Rehabs and also Nimbus Rehabs, to name a few. Quigley formerly stored the leading spot at Dualitas, a biotech that remains in secrecy, depending on to STAT.The soon-to-be Sanofi innovator additionally earlier helmed Therini Bio, an immunotherapy biotech working to develop therapies for neurodegenerative diseases steered by general dysfunction.Just before devoting the last handful of years in biotech, Quigley possesses an even longer record in Huge Pharma, most recently acting as Gilead’s elderly vice head of state of investigation the field of biology till the summer season of 2021.
Prior to that, he clocked in much more than 4 years across different leadership duties at Bristol Myers Squibb and functioned as a medical director at Johnson & Johnson’s Janssen arm before that.Sanofi pointed out Quigley’s mission in his new task would be to “maximize our possibility of excellence through optimum collaborations around our association and beyond, taking best-in-class advancement and also cultivating and sourcing new industry-leading talent along with a dedication to range,” according to an internal memorandum obtained by STAT.